Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer

This study determines the effect of Nab-paclitaxel in combination with IL-15 fusion protein, containing IL-15 and an anti-HSA nanobody domain, on colorectal cancer bearing mice. In vitro binding test of IL15 fusion protein to HSA and Nab-paclitaxel, as well as CTLL-2 cell stimulation assay were perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lipei, Wang, Weiwei, Tian, Jiale, Qi, Chunrun, Cai, Zhengxin, Yan, Wenhui, Xuan, Shihai, Shang, Anquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805949/
https://www.ncbi.nlm.nih.gov/pubmed/35019820
http://dx.doi.org/10.1080/21655979.2021.2023997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805949/
https://www.ncbi.nlm.nih.gov/pubmed/35019820
http://dx.doi.org/10.1080/21655979.2021.2023997

Ejemplares similares